Evidence map›Paper›PMID 38904112›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024.

Camille d'Humières, Anne Fouillet, Laura Verdurme, Stevens-Boris Lakoussan, Yves Gallien, Catherine Coignard, Marie Hervo, Anne Ebel, Anaïs Soares, Benoit Visseaux and 5 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Fulminant parvovirus B19 myocarditis in infants -report of three post-pandemic cases.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  13. Article
  14. Parvovirus B19 Rebound.Journal of medical virology · 2025
    Article
  15. Article
  16. [Epidemiological, clinical, and diagnostic analysis of an outbreak of Parvovirus B19 infection in Mallorca Island].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Observational
  17. Article
  18. Ongoing outbreak of maternal parvovirus B19 infections in Germany since end of 2023: consequence of COVID-19 pandemic?Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Camille d'HumièresThese authors contributed equally to this work and share first authorship.
Anne FouilletThese authors contributed equally to this work and share first authorship.
Laura VerdurmeLaboratoire Cerba, Frépillon, France.
Stevens-Boris LakoussanSanté Publique France, Saint Maurice, France.
Yves GallienSanté Publique France, Saint Maurice, France.
Catherine CoignardLaboratoire Eurofins Biomnis, Ivry sur Seine, France.
Marie HervoLaboratoire Eurofins Biomnis, Lyon, France.
Anne EbelLaboratoire Eurofins Biomnis, Ivry sur Seine, France.
Anaïs SoaresLaboratoire Eurofins Biomnis, Lyon, France.
Benoit VisseauxLaboratoire Cerba, Frépillon, France.
Bruno MaireEst-Rescue, Reims, France.
Pierre-Henry JuanSOS Médecins association, Lyon, France.
Isabelle Parent du ChâteletSanté Publique France, Saint Maurice, France.
Jean-Paul GuthmannSanté Publique France, Saint Maurice, France.
Julien DurandSanté Publique France, Saint Maurice, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From April 2023 to May 2024, an unusual epidemic of parvovirus B19 (B19V) infections occurred in France. The number of B19V IgM-positive serologies was four times higher than in the previous epidemic in 2019. Clinical data from emergency networks corroborated this observation. Morbidity and mortality consequences were observed in children through all data sources. In adults, the increase was only observed in laboratory-confirmed data. Physicians and decisionmakers should be informed in order to better prevent, diagnose and manage at-risk patients.

Indexed as

Disease OutbreaksImmunoglobulin MParvoviridae InfectionsParvovirus B19, HumanAdolescentAdultAgedAntibodies, ViralChildChild, PreschoolErythema InfectiosumFemaleFranceHumansInfantMaleAntibodies, ViralImmunoglobulin MFrancelaboratory surveillancemortalityoutbreakParvovirus B19syndromic surveillance

Identifiers

PMID38904112
PMCPMC11191415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.